Management of atrial fibrillation after transcatheter aortic valve replacement: Challenges and therapeutic considerations
Ammar, Ahmed; Elbatran, Ahmed Ibrahim Mohamed Osman; Wijesuriya, Nadeev; Saberwal, Bunny; Ahsan, Syed Y;
Abstract
Atrial Fibrillation (AF) is very common among patients with severe aortic stenosis. Moreover, new onset AF (NOAF) is a frequent finding after Transcatheter Aortic Valve Replacement (TAVR). There is a significant impact of AF on outcomes in patients undergoing TAVR including mortality, thrombo-embolic and bleeding events. There is lack of clear evidence about the optimal management of AF in TAVR patients. This review aims to summarize the epidemiology, predictors, prognosis, therapeutic considerations and challenges in the management of AF in patients undergoing TAVR.
Other data
Title | Management of atrial fibrillation after transcatheter aortic valve replacement: Challenges and therapeutic considerations | Authors | Ammar, Ahmed; Elbatran, Ahmed Ibrahim Mohamed Osman ; Wijesuriya, Nadeev; Saberwal, Bunny; Ahsan, Syed Y | Keywords | Anticoagulation;Transcatheter aortic valve replacement;Atrial fibrillation | Issue Date | 2021 | Journal | Trends in cardiovascular medicine | Volume | 31 | Issue | 6 | Start page | 361 | End page | 367 | ISSN | 10501738 | DOI | 10.1016/j.tcm.2020.06.007 | PubMed ID | 32599334 | Scopus ID | 2-s2.0-85087411930 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.